论文部分内容阅读
AIM:To examine the cost benefit conferred by the perioperative administration of intravenous tranexamic acid(TXA)in lower limb arthroplasty.METHODS:This study evaluates the use of TXA in 200 consecutive lower limb arthroplasties performed in a single surg